Lucid Diagnostics Inc. Deferred Federal Income Tax Expense (Benefit)
Lucid Diagnostics Inc. (LUCD) reported Deferred Federal Income Tax Expense (Benefit) of -$9.47 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-25
- Lucid Diagnostics Inc. deferred federal income tax expense (benefit) for fiscal 2025 was -$9.47M.
- Lucid Diagnostics Inc. deferred federal income tax expense (benefit) for fiscal 2024 was -$8.03M.
- Lucid Diagnostics Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$9.28M.
- Lucid Diagnostics Inc. deferred federal income tax expense (benefit) for fiscal 2022 was -$12.70M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$9.47M 10-K · filed 2026-03-25 |
| 2024-12-31 | -$8.03M 10-K · filed 2026-03-25 |
| 2023-12-31 | -$9.28M 10-K · filed 2025-03-24 |
| 2022-12-31 | -$12.70M 10-K · filed 2024-03-25 |
| 2021-12-31 | -$4.86M 10-K · filed 2023-03-14 |
| 2020-12-31 | -$1.45M 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |